Clinical Trial Update: Extension Study to Study PQ-110-001 (NCT03140969) [Phase 1, Phase 2]

View source ↗

Summary

An extension study update for PQ-110-001 in Leber congenital amaurosis; the study (NCT03140969) has been terminated with results posted on 2023-01-04.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leber Congenital Amaurosis
• Retinal Diseases

Drugs mentioned

• PQ-110-001 (PQ-110-001)

Snippet

Sponsor: Laboratoires Thea | Conditions: Leber Congenital Amaurosis 10, Blindness | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2023-01-04